MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jhlto.2026.100599

Медицинская библиотека · JHLT open · 2026

Absolute versus change in pulmonary vascular resistance in relation to European Society of Cardiology/European Respiratory Society risk change in pulmonary arterial hypertension.

Donker Stijn C M, Wild Christopher J B, Augustine Daniel X, Suntharalingam Jay, Ross Robert V MacKenzie, van Dijk Arie P J, Maxwell Joseph D, Oxborough David, Thijssen Dick H J

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

In pulmonary arterial hypertension (PAH), it remains unclear whether absolute haemodynamic values or treatment-induced changes are more relevant to subsequent changes in clinical status. As risk classifications are increasingly used to guide clinical management, we evaluated whether pulmonary vascular resistance (PVR) at baseline, after 4 months of therapy, or treatment-induced change better explains risk change.

METHODS

Among 104 screened PAH patients, 69 were included retrospectively. The primary outcome was change in clinical status, defined as a shift in ESC/ERS 4-strata risk classification from baseline to 15 months. Haemodynamics were evaluated via right heart catheterization before and after 4 months of pharmacotherapy. Linear regression examined associations of baseline PVR, 4-month PVR, and ΔPVR with risk change. ROC analyses explored the ability of PVR (baseline, 4-month, and Δ), ΔRVEDP, and ΔCI to discriminate between risk stabilization and worsening.

RESULTS

Risk classification and PVR decreased significantly following treatment (p<0.001). ΔPVR had the highest partial explained variance for risk change (R2=0.118, p=0.003), followed by baseline PVR (R2=0.098, p=0.013). Four-month PVR did not significantly predict risk classification change. In ROC analyses, only ΔPVR significantly discriminated risk stabilization (AUC=0.75, p<0.001). Bootstrapping and permutation confirmed the robustness of these findings.

CONCLUSIONS

The change in PVR after 4 months of treatment outperformed baseline and 4-month PVR, but also other dynamic measures (ΔRVEDP and ΔCI), in explaining changes in 4-strata risk classification and identifying risk stabilization. These findings suggest that ΔPVR provides complementary insight when interpreting serial haemodynamic evaluations in the context of early treatment response in PAH.

Для цитирования: Donker Stijn C M, Wild Christopher J B, Augustine Daniel X, Suntharalingam Jay, Ross Robert V MacKenzie, van Dijk Arie P J, Maxwell Joseph D, Oxborough David, Thijssen Dick H J. Absolute versus change in pulmonary vascular resistance in relation to European Society of Cardiology/European Respiratory Society risk change in pulmonary arterial hypertension.. JHLT open. 2026. DOI: 10.1016/j.jhlto.2026.100599.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.